Treatment of donor-specific antibody-mediated graft rejection by immunochemotherapy, third-party DLI, plasmapheresis and immunoadsorption

Bone Marrow Transplant. 2015 Apr;50(4):613-4. doi: 10.1038/bmt.2014.321. Epub 2015 Jan 26.

Authors

C M Wilk¹, J C Fischer², G Schieren³, J M Rox², R Haas¹, L C Rump³, G Kobbe¹, T Schroeder¹

Affiliations

¹ Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Düsseldorf, Germany.
² Institute for Transplantation Diagnostics and Cell Therapeutics, University Hospital Düsseldorf, Medical Faculty, Düsseldorf, Germany.
³ Department of Nephrology, University Hospital Düsseldorf, Medical Faculty, Düsseldorf, Germany.

PMID: 25621803
DOI: 10.1038/bmt.2014.321

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Allografts
Female
Graft Rejection / etiology
Graft Rejection / therapy*
Humans
Isoantibodies*
Leukemia, Myeloid, Acute / therapy*
Plasmapheresis*
Stem Cell Transplantation*
Unrelated Donors*

Substances

Isoantibodies